GT Biopharma (GTBP)

• Market cap: $7.51M
• 1 day: -0.61%
• 5 days: -5.91%
• 1 month: -8.81%
• 3 months: 5.22%
• 6 months: -64.54%
• Year to date: -13.63%
• 1 year: -70.22%
• 5 years: -99.55%
• 10 years: -99.55%
• Sector: Healthcare
• Industry: Biotechnology

About: GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Employees: 1